Combi-elastography Assessment of Chronic Liver Disease Multi-center Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 818
Summary
- Conditions
- Drug Induced Liver Injury
- Hepatitis B
- Non Alcoholic Fatty Liver
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Cross-Sectional
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
HITACHI developed a new combi-elastography imaging technology combines shear wave imaging and strain imaging technology to make full use of these two imaging modalities and make full use of different physical characteristics for imaging and quantitative analysis. In the study, not only the F index w...
HITACHI developed a new combi-elastography imaging technology combines shear wave imaging and strain imaging technology to make full use of these two imaging modalities and make full use of different physical characteristics for imaging and quantitative analysis. In the study, not only the F index which is related to the stage of liver fibrosis can be obtained, but also the A index which is related to the stage of hepatitis can be obtained, which can not be obtained by other ultrasound devices. This technology is non-invasive, painless, simple and reliable, therefore it is bound to contribute to the early diagnosis of chronic liver disease and the real-time evaluation in the treatment process, which will play an important role in the clinical application.
Tracking Information
- NCT #
- NCT04625166
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ping Liang, Doctor Chinese PLA General Hospital
Get Well Soon